These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33118851)

  • 1. Complex Metal Ions: Neuropsychiatric and Imaging Features.
    Bateman JR; Taber KH; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2020; 32(4):A4-321. PubMed ID: 33118851
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies.
    Mallio CA; Rovira À; Parizel PM; Quattrocchi CC
    Neuroradiology; 2020 Aug; 62(8):925-934. PubMed ID: 32318773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cisplatin nephropathy, contrast media, and creatinine.
    Thomsen HS; Dorph S; Larsen S; Horn T; Hemmingsen L; Skaarup P; Golman K; Svendsen O
    Acad Radiol; 1996 Aug; 3 Suppl 2():S444-6. PubMed ID: 8796625
    [No Abstract]   [Full Text] [Related]  

  • 4. High signal in the cerebrospinal fluid following prior gadolinium administration in a patient with renal impairment.
    Ong EM; Yeh IB
    Singapore Med J; 2007 Nov; 48(11):e296-8. PubMed ID: 17975681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central nervous system neurotoxicity of anticancer chemotherapy].
    Yoshida M
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():475-9. PubMed ID: 25831806
    [No Abstract]   [Full Text] [Related]  

  • 6. Drosophila strain specific response to cisplatin neurotoxicity.
    Groen CM; Podratz JL; Treb K; Windebank AJ
    Fly (Austin); 2018; 12(3-4):174-182. PubMed ID: 30668272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.
    Arlt S; Cepek L; Rustenbeck HH; Prange H; Reimers CD
    J Neurol; 2007 Jun; 254(6):810-2. PubMed ID: 17401744
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of morphological neuroimaging after acute exposure to toxic substances.
    Hantson P; Duprez T
    Toxicol Rev; 2006; 25(2):87-98. PubMed ID: 16958556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity?
    Hui FK; Mullins M
    AJNR Am J Neuroradiol; 2009 Jan; 30(1):E1. PubMed ID: 18635615
    [No Abstract]   [Full Text] [Related]  

  • 10. Is NSF only the tip of the "gadolinium toxicity" iceberg?
    Thomsen HS
    J Magn Reson Imaging; 2008 Aug; 28(2):284-6. PubMed ID: 18666152
    [No Abstract]   [Full Text] [Related]  

  • 11. Gadolinium toxicity: Iron and ferroportin as central targets.
    Swaminathan S
    Magn Reson Imaging; 2016 Dec; 34(10):1373-1376. PubMed ID: 27580520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroradiological features of contrast-induced neurotoxicity: A systematic review and pooled analysis.
    Mariajoseph FP; Yu D; Lai LT; Moore J; Goldschlager T; Chandra RV; Praeger A; Slater LA
    J Clin Neurosci; 2024 Aug; 126():108-116. PubMed ID: 38870639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation.
    Bjur KA; Payne ET; Nemergut ME; Hu D; Flick RP
    J Child Neurol; 2017 May; 32(6):594-602. PubMed ID: 28424007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine profiles and kidney histology after ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy.
    Thomsen HS; Dorph S; Larsen S; Horn T; Hemmingsen L; Skaarup P; Golman K; Svendsen O
    Acad Radiol; 1995 Aug; 2(8):675-82. PubMed ID: 9419624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Gadolinium-Based Contrast Agents on the Cerebellum: from Basic Research to Neurological Practice and from Pregnancy to Adulthood.
    Ariyani W; Khairinisa MA; Perrotta G; Manto M; Koibuchi N
    Cerebellum; 2018 Jun; 17(3):247-251. PubMed ID: 29196974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrogenic systemic fibrosis (NSF): Effects of stricter guidelines on the use of contrast media containing gadolinium].
    Hägele J; Simon M
    Radiologe; 2011 Oct; 51(10):831-2. PubMed ID: 21947240
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier.
    Takahashi M; Tsutsui H; Murayama C; Miyazawa T; Fritz-Zieroth B
    Magn Reson Imaging; 1996; 14(6):619-23. PubMed ID: 8897365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of gadolinium chelates in rodents.
    Nunn AD; Wedeking P; Marinelli E; Ranganathan R; Kumar K; Pillai R; Tweedle M
    Acad Radiol; 1996 Aug; 3 Suppl 2():S333-5. PubMed ID: 8796596
    [No Abstract]   [Full Text] [Related]  

  • 19. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
    Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
    Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
    Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
    Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.